Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

Katsumata N, Yasuda M, Takahashi F, Isonishi S, Jobo T, Aoki D, Tsuda H, Sugiyama T, Kodama S, Kimura E, Ochiai K, Noda K; Japanese Gynecologic Oncology Group.

Lancet. 2009 Oct 17;374(9698):1331-8. doi: 10.1016/S0140-6736(09)61157-0. Epub 2009 Sep 18.

PMID:
19767092
2.

Dose-dense approaches to ovarian cancer treatment.

Katsumata N.

Curr Treat Options Oncol. 2015 May;16(5):21. doi: 10.1007/s11864-015-0338-4. Review.

PMID:
25859831
3.

Dose-dense therapy is of benefit in primary treatment of ovarian cancer? In favor.

Katsumata N.

Ann Oncol. 2011 Dec;22 Suppl 8:viii29-viii32. doi: 10.1093/annonc/mdr468. Review.

PMID:
22180396
4.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
5.

Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis.

Marchetti C, De Felice F, Musella A, Palaia I, Monti M, Musio D, Muzii L, Tombolini V, Benedetti Panici P.

Oncotarget. 2016 Sep 6;7(36):58709-58715. doi: 10.18632/oncotarget.11094. Review.

6.

First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?

du Bois A, Neijt JP, Thigpen JT.

Ann Oncol. 1999;10 Suppl 1:35-41. Review.

PMID:
10219451
7.

Dose-dense paclitaxel in advanced ovarian cancer.

Kumar A, Hoskins PJ, Tinker AV.

Clin Oncol (R Coll Radiol). 2015 Jan;27(1):40-7. doi: 10.1016/j.clon.2014.10.001. Epub 2014 Nov 4. Review.

PMID:
25455846
8.

Is intraperitoneal chemotherapy still an acceptable option in primary adjuvant chemotherapy for advanced ovarian cancer?

Monk BJ, Chan JK.

Ann Oncol. 2017 Nov 1;28(suppl_8):viii40-viii45. doi: 10.1093/annonc/mdx451. Review.

PMID:
29232474
9.

Weekly paclitaxel in the treatment of recurrent ovarian cancer.

Baird RD, Tan DS, Kaye SB.

Nat Rev Clin Oncol. 2010 Oct;7(10):575-82. doi: 10.1038/nrclinonc.2010.120. Epub 2010 Aug 3. Review.

PMID:
20683437
10.
11.

Dose-dense weekly chemotherapy in advanced ovarian cancer: An updated meta-analysis of randomized controlled trials.

Marchetti C, De Felice F, Di Pinto A, D'Oria O, Aleksa N, Musella A, Palaia I, Muzii L, Tombolini V, Benedetti Panici P.

Crit Rev Oncol Hematol. 2018 May;125:30-34. doi: 10.1016/j.critrevonc.2018.02.016. Epub 2018 Mar 7. Review.

PMID:
29650273
12.

Dose-dense and dose-intense chemotherapy for small cell ovarian cancer: 2 cases and review of literature.

Shrimali RK, Correa PD, Reed NS.

Med Oncol. 2011 Sep;28(3):766-70. doi: 10.1007/s12032-010-9509-0. Epub 2010 Apr 2. Review.

PMID:
20361360
13.

Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review.

Swart AM, Burdett S, Ledermann J, Mook P, Parmar MK.

Ann Oncol. 2008 Apr;19(4):688-95. Epub 2007 Nov 15. Review.

PMID:
18006894
14.

Historical progress in the initial management of ovarian cancer: intraperitoneal chemotherapy.

Coleman RL, Sood AK.

Curr Oncol Rep. 2006 Nov;8(6):455-64. Review.

PMID:
17040624
16.

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions.

Karam A, Ledermann JA, Kim JW, Sehouli J, Lu K, Gourley C, Katsumata N, Burger RA, Nam BH, Bacon M, Ng C, Pfisterer J, Bekkers RLM, Casado Herráez A, Redondo A, Fujiwara H, Gleeson N, Rosengarten O, Scambia G, Zhu J, Okamoto A, Stuart G, Ochiai K; participants of the 5th Ovarian Cancer Consensus Conference.

Ann Oncol. 2017 Apr 1;28(4):711-717. doi: 10.1093/annonc/mdx011.

PMID:
28327917
17.

Front-line therapy of advanced ovarian cancer: new approaches.

Ledermann JA.

Ann Oncol. 2017 Nov 1;28(suppl_8):viii46-viii50. doi: 10.1093/annonc/mdx452. Review.

PMID:
29232475
18.

Current and future directions of clinical trials for ovarian cancer.

Gardner GJ, Jewell EL.

Cancer Control. 2011 Jan;18(1):44-51. Review.

PMID:
21273979
19.

Chemotherapy of ovarian cancer in elderly patients.

Troso-Sandoval TA, Lichtman SM.

Cancer Biol Med. 2015 Dec;12(4):292-301. doi: 10.7497/j.issn.2095-3941.2015.0077. Review.

Supplemental Content

Support Center